Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
Authors
Posts by lungcanc
lungcanc
526 POSTS
0 COMMENTS
The Peaks and Valleys in Lung Cancer Therapeutics Research
lungcanc
Ki-67 in Pulmonary Neuroendocrine Tumors: Where Do We Stand?
lungcanc
PCI Decreases the Risk of Brain Metastases in Patients with Locally...
lungcanc
What Can We Offer a Patient with a Malignant Mesothelioma?
lungcanc
2019 IASLC Best of the World Lung Cancer Conference Results in...
lungcanc
The IASLC and the International Thoracic Oncology Nursing Forum: Celebrating Collaboration
lungcanc
IASLC 2019 Mesothelioma Meeting Offers Innovative Approach for Rapid Learning
lungcanc
IASLC Targeted Therapies of Lung Cancer Meeting Draws Record Abstract Submissions,...
lungcanc
Checkpoint Inhibitors and Clinical Decision Making: A Q&A with Dr. Nasser...
lungcanc
Scott Antonia, MD, PhD
lungcanc
1
...
15
16
17
...
53
Page 16 of 53
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS
